Wildcat Capital Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-415,765
| Closed | -$1.11M | – | 35 |
|
|
2019
Q2 | $1.11M | Hold |
415,765
| – | – | 0.48% | 19 |
|
|
2019
Q1 | $1.98M | Hold |
415,765
| – | – | 1.16% | 15 |
|
|
2018
Q4 | $998K | Hold |
415,765
| – | – | 0.66% | 14 |
|
|
2018
Q3 | $1.83M | Hold |
415,765
| – | – | 1.41% | 11 |
|
|
2018
Q2 | $2.99M | Hold |
415,765
| – | – | 2.29% | 10 |
|
|
2018
Q1 | $2.14M | Sell |
415,765
-1,322,467
| -76% | -$6.81M | 1.77% | 12 |
|
|
2017
Q4 | $6.61M | Sell |
1,738,232
-1,061,558
| -38% | -$4.03M | 7.03% | 4 |
|
|
2017
Q3 | $4.76M | Hold |
2,799,790
| – | – | 0.85% | 9 |
|
|
2017
Q2 | $5.6M | Hold |
2,799,790
| – | – | 1.49% | 7 |
|
|
2017
Q1 | $11.1M | Hold |
2,799,790
| – | – | 3.5% | 4 |
|
|
2016
Q4 | $13.7M | Hold |
2,799,790
| – | – | 6.31% | 4 |
|
|
2016
Q3 | $21.7M | Hold |
2,799,790
| – | – | 6.53% | 4 |
|
|
2016
Q2 | $15.7M | Buy |
2,799,790
+176,257
| +7% | +$987K | 5.91% | 4 |
|
|
2016
Q1 | $14.1M | Hold |
2,623,533
| – | – | 4.91% | 4 |
|
|
2015
Q4 | $22.9M | Buy |
2,623,533
+912,470
| +53% | +$7.95M | 6.45% | 4 |
|
|
2015
Q3 | $14.4M | Buy |
1,711,063
+975,051
| +132% | +$8.18M | 5.36% | 4 |
|
|
2015
Q2 | $13M | Buy |
+736,012
| New | +$13M | 4.44% | 4 |
|